Rocksauce Fire

Description

The product is a liquid formulation intended for oral administration, packaged in a 12 oz container. It contains an active ingredient, the specifics of which are not provided. The formulation also includes inactive ingredients, details of which are not specified. The product is designed for a specific indication, which is not detailed in the provided information.

Uses and Indications

This drug is indicated for the soothing relief of discomfort associated with cold, sore muscles, and joints.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to apply the lotion liberally to the area of pain, ensuring thorough massage until the lotion is fully absorbed into the skin. This application should be repeated 3 to 4 times daily to achieve optimal therapeutic effects.

For storage, the lotion should be kept at a temperature range of 68° to 77°F (20° to 25°C) to maintain its efficacy.

Contraindications

Use is contraindicated in the following situations:

Heating, microwaving, or adding to hot water or any container where heating may cause splattering is contraindicated due to the risk of burns. Application to the eyes or directly on mucous membranes is prohibited to prevent irritation or injury. Ingestion by mouth or placement in the nostril is contraindicated to avoid potential adverse effects. Application to wounds or damaged skin is not recommended to prevent complications. Additionally, use should strictly adhere to the provided directions to ensure safety and efficacy.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes, mucous membranes, or broken skin to prevent adverse reactions.

In the event of irritation, it is recommended that the individual consult a healthcare professional prior to use, particularly if pregnant, breastfeeding, or possessing sensitive skin. Should irritation develop during use, it is advised to discontinue application and seek medical advice.

In cases of accidental ingestion, immediate medical assistance should be sought, or the individual should contact a Poison Control Center without delay to ensure appropriate management.

Healthcare professionals should remain vigilant regarding these warnings and precautions to ensure the safe use of the product.

Side Effects

Patients should be aware that the product is intended for external use only and must be kept away from the eyes, mucous membranes, and broken skin to prevent adverse reactions.

In clinical practice, it is advised that patients consult a healthcare professional and discontinue use if any irritation occurs. Additionally, individuals who are pregnant or breastfeeding should seek guidance from a health professional prior to use. Those with sensitive skin are also encouraged to consult a healthcare provider before starting treatment to mitigate the risk of adverse effects.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Rocksauce Fire (methyl salicylate, menthol and capsaicin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully known. Therefore, it is essential for women of childbearing potential to seek medical advice prior to use to ensure appropriate management and consideration of any potential risks.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication if they are breastfeeding. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of accidental ingestion. It is important to inform patients that if they experience irritation, they should consult a health professional before use, particularly if they are pregnant, breastfeeding, or have sensitive skin.

Providers should emphasize that the product should not be heated, microwaved, or added to hot water, as this may cause splattering and result in burns. Patients should be cautioned against using the product in or around the eyes, directly on mucous membranes, by mouth, or in the nostrils, as well as on wounds or damaged skin. It is essential to instruct patients to use the product only as directed and to avoid any other uses.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 68° to 77°F (20° to 25°C) to maintain its integrity and efficacy.

Care should be taken to avoid heating the product; it must not be heated, microwaved, or placed in hot water. Additionally, it should not be stored in any container that may cause heating water to splatter, as this could result in burns. Proper handling and storage conditions are crucial to ensure the safety and effectiveness of the product.

Additional Clinical Information

The product is administered topically, with patients advised to apply the lotion liberally to the area of pain and massage until fully absorbed into the skin. This application should be repeated 3-4 times daily.

Clinicians should counsel patients to consult a doctor and discontinue use if irritation occurs. Additionally, patients are encouraged to seek advice from a health professional before use if they are pregnant, breastfeeding, or have sensitive skin.

Drug Information (PDF)

This file contains official product information for Rocksauce Fire, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)